Article Text

Download PDFPDF
Endometrial Cancer State of the Science Meeting
  1. Henry C. Kitchener* and
  2. Edward L. Trimble
  1. * UK National Cancer Research Institute and University of Manchester, Manchester, United Kingdom; and
  2. National Cancer Institute, Bethesda,MD.
  1. Address correspondence and reprint requests to Edward L. Trimble, CIB,CTEP, DCTD, National Cancer Institute, National Institutes of Health 610 Executive Blvd, Suite 7025, Bethesda, MD 20892. E-mail: tt6m{at}


There is a pressing need to improve our understanding of endometrial cancer (EC) and uterine carcinosarcoma and to develop new treatment strategies to improve outcomes. In recognition of this, a State of the Science meeting on EC was held last November 28 and 29, 2006, in Manchester, United Kingdom. The meeting was cosponsored by the National Cancer Research Institute (UK), the National Cancer Institute (US), and the Gynecological Cancer Intergroup.

The objectives of the meeting were as follows:

  1. To review current knowledge and understanding of EC and its treatments.

  2. To identify key issues for translational research and clinical trials.

  3. To identify the most important trials for women with endometrial carcinoma and uterine carcinosarcoma, both those already underway or to be done, for which the Gynecological Cancer Intergroup might facilitate international cooperation.

  • Endometrial cancer
  • Clinical trials
  • Translational research

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.